Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Mycopathologia ; 170(5): 315-30, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20552280

RESUMO

A model of pulmonary cryptococcosis in immunocompetent rats was developed to better understand the virulence of Cryptococcus gattii. Six isolates were studied, representing four molecular genotypes (VGI-MATα, VGIIa-MATα, VGIIa-MAT a, VGIIb-MATα), obtained from Australia, Vancouver (Canada) and Colombia. These originated from human patients, a cat and the environment and were administered intratracheally (i.t.) or transthoracically into Fischer 344 or Wistar-Furth rats in doses varying from 10(4) to 10(7) colony-forming units (CFU) in 0.1 ml of saline. With the exception of animals given the VGIIa-MAT a isolate, rats consistently became ill or died of progressive cryptococcal pneumonia following i.t. doses exceeding 10(7) CFU. Affected lungs increased in weight up to tenfold and contained numerous circumscribed, gelatinous lesions. These became larger and more extensive, progressing from limited hilar and/or tracheal lesions, to virtually confluent gelatinous masses. Disease was localized to the lungs for at least 3-4 weeks, with dissemination to the brain occurring in some animals after day 29. The dose-response relationship was steep for two VGI isolates studied (human WM179, environmental WM276); doses up to 10(6) CFU i.t. did not produce lesions, while 10(7) or more yeast cells produced progressive pneumonia. Intratracheal inoculation of rats with C. gattii provides an excellent model of human pulmonary cryptococcosis in healthy hosts, mimicking natural infections. Disease produced by C. gattii in rats is distinct from that caused by C. neoformans in that infections are progressive and ultimately fatal.


Assuntos
Criptococose/microbiologia , Criptococose/patologia , Cryptococcus gattii/patogenicidade , Modelos Animais de Doenças , Pneumopatias Fúngicas/microbiologia , Pneumopatias Fúngicas/patologia , Animais , Austrália , Encéfalo/microbiologia , Encéfalo/patologia , Canadá , Doenças do Gato/microbiologia , Gatos , Colômbia , Criptococose/mortalidade , Cryptococcus gattii/classificação , Cryptococcus gattii/isolamento & purificação , Microbiologia Ambiental , Feminino , Humanos , Pulmão/microbiologia , Pulmão/patologia , Pneumopatias Fúngicas/mortalidade , Masculino , Ratos , Ratos Endogâmicos F344 , Ratos Endogâmicos WF , Fatores de Tempo , Virulência
3.
Dev Biol ; 340(2): 408-18, 2010 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-20122915

RESUMO

Fragile X mental retardation protein (FMRP) is an RNA-binding protein that is required for the translational regulation of specific target mRNAs. Loss of FMRP causes Fragile X syndrome (FXS), the most common form of inherited mental retardation in humans. Understanding the basis for FXS has been limited because few in vivo targets of FMRP have been identified and mechanisms for how FMRP regulates physiological targets are unclear. We have previously demonstrated that Drosophila FMRP (dFMRP) is required in early embryos for cleavage furrow formation. In an effort to identify new targets of dFMRP-dependent regulation and new effectors of cleavage furrow formation, we used two-dimensional difference gel electrophoresis and mass spectrometry to identify proteins that are misexpressed in dfmr1 mutant embryos. Of the 28 proteins identified, we have identified three subunits of the Chaperonin containing TCP-1 (CCT) complex as new direct targets of dFMRP-dependent regulation. Furthermore, we found that the septin Peanut, a known effector of cleavage, is a likely conserved substrate of fly CCT and is mislocalized in both cct and in dfmr1 mutant embryos. Based on these results we propose that dFMRP-dependent regulation of CCT subunits is required for cleavage furrow formation and that at least one of its substrates is affected in dfmr1- embryos suggesting that dFMRP-dependent regulation of CCT contributes to the cleavage furrow formation phenotype.


Assuntos
Chaperonina com TCP-1/metabolismo , Proteínas de Drosophila/metabolismo , Drosophila/metabolismo , Proteína do X Frágil da Deficiência Intelectual/metabolismo , Regulação da Expressão Gênica no Desenvolvimento , Sequência de Aminoácidos , Animais , Blástula/embriologia , Chaperonina com TCP-1/química , Chaperonina com TCP-1/genética , Drosophila/embriologia , Drosophila/genética , Proteínas de Drosophila/genética , Eletroforese em Gel Bidimensional , Embrião não Mamífero/metabolismo , Imunofluorescência , Proteína do X Frágil da Deficiência Intelectual/genética , Síndrome do Cromossomo X Frágil/genética , Síndrome do Cromossomo X Frágil/metabolismo , Espectrometria de Massas , Dados de Sequência Molecular , Mutação , Subunidades Proteicas/química , Subunidades Proteicas/genética , Proteômica/métodos , Homologia de Sequência de Aminoácidos , Especificidade por Substrato
4.
Electrophoresis ; 30 Suppl 1: S156-61, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19517495

RESUMO

Difference gel electrophoresis (DIGE) was invented to circumvent the inherent variability of 2-DE. This variability is a natural consequence of separating thousands of proteins over a large space, such as a 15 x 20 cm slab of polyacrylamide gel. The originators of 2-DE envisioned being able to compare cancerous cells and normal cells to understand what makes these cells different. Gel-to-gel variability made this an extremely difficult task. We reasoned that if both samples could be run on the same gel, then the inherent variability would be obviated. Thus, we created matched sets of fluorescent dyes that allows one to compare two or three protein samples on a single gel. In the 12 years since the description of DIGE first appeared in Electrophoresis, this founding paper has been cited over 660 times. This review highlights some of the improvements and applications of DIGE. We hope these examples are illustrative of what has been done and where the field is headed.


Assuntos
Eletroforese em Gel Bidimensional/métodos , Corantes Fluorescentes/análise , Proteínas/análise , Proteômica/métodos , Animais , Humanos , Proteínas/genética , Proteínas/metabolismo
5.
Mol Biosyst ; 4(11): 1126-35, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18931788

RESUMO

Ventral furrow formation is the first morphogenetic movement to occur during Drosophila gastrulation causing the internalization of mesodermal precursors. A previous proteomic screen for ventral-specific proteome changes identified a set of about forty "difference-proteins" that spanned many cellular functions. To understand the connections between these disparate proteins, we initiated a pathway-building scheme using cycles of protein expression manipulation and proteome analysis. This pathway-building exercise started with the proteasomal subunit, Pros35, one of three proteasome subunits found to be ventral-specific difference-proteins. Here we show that Pros35 is a key regulator in ventral furrow formation. Altering the level of Pros35 led to ventral furrow defects. Proteome analysis of the changes induced by Pros35 RNAi showed extensive overlap with the original set of ventral-specific difference-proteins. One of the most prominent changes was in the extracellular iron carrier, Transferrin (Tsf1). Tsf1 is normally less abundant in ventral cells relative to lateral cells; however, RNAi of Pros35 in ventralized embryos negated this ventral-specific difference. Increasing Tsf1 in wild-type embryos blocked ventral furrow formation and caused proteome changes that were similar to the previously seen ventral-specific difference-proteins, including Pros35, which indicates the existence of an unprecedented regulatory loop between the proteasome and iron homeostasis. Additionally, we show that the iron regulatory protein, Irp-1A, also plays an important role in ventral furrow formation. Together these three proteins are part of a regulatory loop that coordinately controls a large number of ventral-specific protein changes.


Assuntos
Proteínas de Drosophila/metabolismo , Drosophila/embriologia , Animais , Padronização Corporal , Drosophila/metabolismo , Proteínas de Drosophila/genética , Embrião não Mamífero/metabolismo , Gastrulação , Proteína 1 Reguladora do Ferro/metabolismo , Proteômica , Interferência de RNA , Transdução de Sinais , Transferrina/metabolismo
6.
Proc Natl Acad Sci U S A ; 102(34): 12023-8, 2005 Aug 23.
Artigo em Inglês | MEDLINE | ID: mdl-16099838

RESUMO

MicroRNAs (miRNAs) are a class of small RNAs that silence gene expression. In animal cells, miRNAs bind to the 3' untranslated regions of specific mRNAs and inhibit their translation. Although some targets of a handful of miRNAs are known, the number and identities of mRNA targets in the genome are uncertain, as are the developmental functions of miRNA regulation. To identify the global range of miRNA-regulated genes during oocyte maturation of Drosophila, we compared the proteome from wild-type oocytes with the proteome from oocytes lacking the dicer-1 gene, which is essential for biogenesis of miRNAs. Most identified proteins appeared to be subject to translation inhibition. Their transcripts contained putative binding sites in the 3' untranslated region for a subset of miRNAs, based on computer modeling. The fraction of genes subject to direct and indirect repression by miRNAs during oocyte maturation appears to be small (4%), and the genes tend to share a common functional relationship in protein biogenesis and turnover. The preponderance of genes that control global protein abundance suggests this process is under tight control by miRNAs at the onset of fertilization.


Assuntos
Inativação Gênica , Genes/genética , MicroRNAs/metabolismo , Oócitos/metabolismo , Proteoma/metabolismo , Regiões 3' não Traduzidas/genética , Animais , Pareamento de Bases , Sequência de Bases , Biologia Computacional , Primers do DNA , Drosophila , Eletroforese , Feminino , Espectrometria de Massas , MicroRNAs/genética , Dados de Sequência Molecular , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Ribonuclease III/genética , Análise de Sequência de DNA
8.
J Pharm Pharmacol ; 56(3): 285-9, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15025852

RESUMO

Histatins are a group of antimicrobial peptides, found in the saliva of man and some higher primates, which possess antifungal properties. Histatins bind to a receptor on the fungal cell membrane and enter the cytoplasm where they target the mitochondrion. They induce the non-lytic loss of ATP from actively respiring cells, which can induce cell death. In addition, they have been shown to disrupt the cell cycle and lead to the generation of reactive oxygen species. Their mode of action is distinct from those exhibited by the conventional azole and polyene drugs, hence histatins may have applications in controlling drug-resistant fungal infections. The possibility of utilising histatins for the control of fungal infections of the oral cavity is being actively pursued with the antifungal properties of topical histatin preparations and histatin-impregnated denture acrylic being evaluated. Initial clinical studies are encouraging, having demonstrated the safety and efficacy of histatin preparations in blocking the adherence of the yeast Candida albicans to denture acrylic, retarding plaque formation and reducing the severity of gingivitis. Histatins may represent a new generation of antimicrobial compounds for the treatment of oral fungal infections and have the advantage, compared with conventional antifungal agents, of being a normal component of human saliva with no apparent adverse effects on host tissues and having a mode of action distinct to azole and polyene antifungals.


Assuntos
Antibacterianos/uso terapêutico , Antifúngicos/uso terapêutico , Previsões , Peptídeos , Proteínas/uso terapêutico , Animais , Antibacterianos/química , Antifúngicos/química , Antifúngicos/farmacologia , Humanos , Proteínas/química , Proteínas/farmacologia , Saliva/química
9.
Development ; 131(3): 643-56, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14711877

RESUMO

Ventral furrow formation is a key morphogenetic event during Drosophila gastrulation that leads to the internalization of mesodermal precursors. While genetic analysis has revealed the genes involved in the specification of ventral furrow cells, few of the structural proteins that act as mediators of ventral cell behavior have been identified. A comparative proteomics approach employing difference gel electrophoresis was used to identify more than fifty proteins with altered abundance levels or isoform changes in ventralized versus lateralized embryos. Curiously, the majority of protein differences between these embryos appeared well before gastrulation, only a few protein changes coincided with gastrulation, suggesting that the ventral cells are primed for cell shape change. Three proteasome subunits were found to differ between ventralized and lateralized embryos. RNAi knockdown of these proteasome subunits and time-dependent difference-proteins caused ventral furrow defects, validating the role of these proteins in ventral furrow morphogenesis.


Assuntos
Drosophila/embriologia , Embrião não Mamífero/metabolismo , Proteoma/metabolismo , Animais , Drosophila/metabolismo , Eletroforese em Gel Bidimensional , Proteínas/classificação , Fatores de Tempo
10.
Microbes Infect ; 5(4): 285-90, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12706441

RESUMO

Primary lung infection with Cryptococcus neoformans is characterised by circumscribed lesions (cryptococcomas). To identify cryptococcal and/or host products of importance in pathogenesis, we applied proton nuclear magnetic resonance (NMR) spectroscopy, which identifies mobile compounds present in complex mixtures, to experimental pulmonary cryptococcomas from rats. Magnetic resonance experiments were performed on cryptococcomas (n = 10) and healthy lungs (n = 8). Signal assignment to key metabolites was confirmed by homo-nuclear and hetero-nuclear NMR correlation spectroscopy. Cryptococcal metabolites, dominating spectra from cryptococcomas included the stress protectants, trehalose and mannitol, acetate, and in some animals, ethanol. Glycerophosphorylcholine was also abundant in cryptococcomas, consistent with hydrolysis of phospholipids in vivo by the cryptococcal enzyme, phospholipase B (PLB). PLB has been identified by molecular studies as a cryptococcal virulence determinant. We propose that PLB secreted by cryptococci promotes tissue invasion by hydrolysing host phospholipids, such as dipalmitoyl phosphatidyl choline, which is abundant in pulmonary surfactant, and lung cell membrane phospholipids. Our results confirm the utility of NMR spectroscopy in studies of microbial pathogenesis.


Assuntos
Criptococose/microbiologia , Cryptococcus neoformans/patogenicidade , Pneumopatias Fúngicas/microbiologia , Espectroscopia de Ressonância Magnética , Animais , Células Cultivadas , Criptococose/patologia , Cryptococcus neoformans/isolamento & purificação , Cryptococcus neoformans/metabolismo , Cryptococcus neoformans/ultraestrutura , Feminino , Pulmão/microbiologia , Pulmão/ultraestrutura , Pneumopatias Fúngicas/patologia , Ratos , Ratos Endogâmicos F344
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...